Generation of HER2-Specific Antibody Immunity During Adjuvant Trastuzumab and Reduced Relapse in Resected HER2 Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Breast Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Generation of HER2-Specific Antibody Immunity During Trastuzumab Adjuvant Therapy Associates With Reduced Relapse in Resected HER2 Breast Cancer
Breast Cancer Res 2018 Jun 14;20(1)52, N Norton, N Fox, CA McCarl, KS Tenner, K Ballman, CL Erskine, BM Necela, D Northfelt, WW Tan, C Calfa, M Pegram, G Colon-Otero, EA Perez, R Clynes, KL KnutsonFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.